ACS guidelines Pre-program To understand the ACS guidelines it is necessary to know mortality risk if you do nothing and bleeding risk for different kinds of treatment. We make therefore use of the GRACE score (mortality ) CRUSADE score (bleeding) 8-4-2015 Eduard van den Berg, cardio.nl 1 8-4-2015 Eduard van den Berg, cardio.nl 2 8-4-2015 Eduard van den Berg, cardio.nl 3 8-4-2015 Eduard van den Berg, cardio.nl 4 8-4-2015 Eduard van den Berg, cardio.nl 5 GRACE score best score for ACS at the moment 050212 Eduard van den Berg, cardio.nl 6 Mortality after Acute Coronary Syndromes 8 7 6 STE MI Trop 0 - 0.25 Trop 0.25 - 1.0 5 4 3 2 1 0 0 - 10 days 8-4-2015 11 - 30 days 31 - 90 90 - 180 days days >180 days Eduard van den Berg, cardio.nl Cumulative: 13.6% Blue 10.6% Green 11.6% Red 7 Do we need risk scoring ? Risk scoring leeds to lower mortality 8-4-2015 Eduard van den Berg, cardio.nl 8 Evolving ACS Guidelines • Revised diagnosis – IAP to NSTEMI – Troponin and HS-Troponin – Increasing awareness of prognosis NSTEMI • Take account of new data – Improved risk scoring • Allow for improved hospital facilities – cath lab facilites; functional imaging 8-4-2015 Eduard van den Berg, cardio.nl 9 Why another risk scoring ? • Commonest reason for non-referral – Patients “not at high enough risk” • Analysis of records of those not referred – 59.1% at intermediate or high risk according to baseline TIMI risk score • Over reliance on one or two key risk factors – ECG and Tn – Under use of other variables : age, CCF, renal function • Decrease of bed capacity 8-4-2015 Eduard van den Berg, cardio.nl 10 ACS Risk Scoring • TIMI – – – – Age - Use of aspirin Risk Factors - Known CAD > 1 episode rest pain - ST segment deviation Cardiac risk markers • PURSUIT – Age, Sex – Signs of CCF - CCS class in last 6/52 - ST depression on ECG • GRACE – – – – 8-4-2015 Age - Heart rate and systolic BP Creatinine - CCF (Killip class) Cardiac arrest at admission Elevated cardiac markers - ST segment deviation Eduard van den Berg, cardio.nl 11 ACS Risk Scoring • TIMI – – – – Age - Use of aspirin Risk Factors - Known CAD > 1 episode rest pain - ST segment deviation Cardiac risk markers • PURSUIT – Age, Sex – Signs of CCF - CCS class in last 6/52 - ST depression on ECG • GRACE – – – – 8-4-2015 Age - Heart rate and systolic BP Creatinine - CCF (Killip class) Cardiac arrest at admission Elevated cardiac markers - ST segment deviation Eduard van den Berg, cardio.nl 12 ACS Risk Scores • Balance between complexity and utility • Score that include continuous variables more powerful but more complex to compute – Simple PC/PDA programmes now available • Objective data more robust •GRACE most powerful and has most objective data 8-4-2015 Eduard van den Berg, cardio.nl 13 How was GRACE introduced ? Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE) Kim A. Eagle, Shaun G. Goodman, Álvaro Avezum, Andrzej Budaj, Cynthia M. Sullivan, José López-Sendón, for the GRACE Investigators Lancet 2002;359:373-77 8-4-2015 Eduard van den Berg, cardio.nl 14 Missed Opportunities for Reperfusion ST ↑ or LBBB, <12 hrs from onset, no contraindications n PCI alone Lytic alone Both Neither ANC (%) 269 US (%) 327 AB (%) EUR (%) 339 739 1.1 66.9 2.2 29.7 17.7 30.6 18.7 33.0 13.9 53.1 5.0 28.0 16.2 49.4 4.9 29.5 AB, Argentina/Brazil; ANC, Australia/New Zealand/Canada; EUR, Europe; US, United States Eagle KA et al. Lancet 2002;359:373-7. 8-4-2015 Eduard van den Berg, cardio.nl 15 Independent Predictors of No Reperfusion Variable OR (95% CI) Prior CABG History of diabetes History of congestive heart failure Presentation without chest pain *Age 75 years 2.28 (1.35 - 3.87) 1.46 (1.11 -1.94) 2.92 (1.84 - 4.67) 2.23 (2.13 - 4.89) 2.37 (1.82 - 3.08) *As compared to the <55 years age group Eagle KA et al. Lancet 2002;359:373-7. 8-4-2015 Eduard van den Berg, cardio.nl 16 Geographical Variation: Admission to Hospitals with/without Access to Cath Lab 100 Cath lab 80 82 78 80 Patients (%) No cath lab 61 60 39 40 20 22 18 20 0 USA Europe ANC AB ANC, Australia/New Zealand/Canada; AB, Argentina/Brazil 8-4-2015 Eduard van den Berg, cardio.nl 17 Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: Insights from the Global Registry of Acute Coronary Events (GRACE) Andrzej Budaj, David Brieger, Ph Gabriel Steg, Shaun G. Goodman, Omar H. Dabbous, Keith A. A. Fox, Álvaro Avezum, Christopher P. Cannon, Tomasz Mazurek, Marcus D. Flather, and Frans Van De Werf, for the GRACE Investigators Am Heart J 2003;146:999-1006. 8-4-2015 Eduard van den Berg, cardio.nl 18 Geographic Practice Variation 100 92 92 91 95 United States Australia/New Zealand/Canada Patients (%) 80 Europe 65 Argentina/Brazil 58 60 40 37 39 33 30 24 20 17 15 8 9 13 0 PCI GP IIb/IIIa LMWH ASA Budaj A et al. Am Heart J 2003;146:999-1006. 8-4-2015 Eduard van den Berg, cardio.nl 19 Incidence of Major Bleeding Patients (%) 9 6 UFH LMWH UFH + IIb/IIIa LMWH + IIb/IIIa 8.3 3.9 3 2.4 2.9 0 Major bleed Cannon CP et al.Eur Heart J 2001;22(Abstr Suppl):592. 8-4-2015 Eduard van den Berg, cardio.nl 20 In-Hospital Mortality Rates 50 No Major Bleed Major Bleed Patients (%) 40 30 ** 18.6 20 10 5.1 **16.1 ** ** 15.3 5.3 3.0 22.8 7.0 0 Overall Unstable Angina NSTEMI STEMI Moscucci M et al.Eur Heart J 2003;24:1815-23. **P<0.001 8-4-2015 Eduard van den Berg, cardio.nl 21 Hospital Outcomes of ACS Patients Stratified by Statin Use Outcome Prior statins Only Prior & Hospital Statin Hospital Statins Only Death 1.39 (0.91,2.14) 0.20 (0.16,0.25) 0.38 (0.30,0.48) Recurrent MI 0.69 (0.43,1.11) 0.90 (0.75,1.07) 1.22 (1.08,1.37) Stroke 1.08 (0.43,2.73) 0.68 (0.42, 1.12) 0.80 (0.57, 1.14) Composite 1.02 (0.74,1.41) 0.66 (0.56,0.77) 0.87 (0.78,0.97) *Compared to patients never receiving statins Ann. Intern Med. 2004;140:856-866. 8-4-2015 Eduard van den Berg, cardio.nl 22 At Admission Risk Model 8-4-2015 Eduard van den Berg, cardio.nl 23 At Discharge Risk Model 8-4-2015 Eduard van den Berg, cardio.nl 24 GRACE PDA Software 8-4-2015 Eduard van den Berg, cardio.nl 25 Manuscript Status 66 Published/in press Submitted/being revised 12 7 Edit/write assistance Top priority independent 8 16 Unprioritized 0 8-4-2015 20 40 Eduard van den Berg, cardio.nl 60 80 26 Unique Features of GRACE • Multi-national perspective • Full spectrum of coronary syndromes • Increased data on demographics, presentation, management and outcome • Regular audits of data quality • Feedback to participating sites • Long follow-up 8-4-2015 Eduard van den Berg, cardio.nl 27 Guide to GRACE manuscripts (1999 to 2006) http://www.outcomes-umassmed.org/grace/guide_to_grace_manuscripts.aspx 8-4-2015 Eduard van den Berg, cardio.nl 28 8-4-2015 Eduard van den Berg, cardio.nl 29 Bleeding Risk Score Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Earl implementation of the American College of Cardiology/American Heart Association guidelines (CRUSADE) 8-4-2015 Eduard van den Berg, cardio.nl 30 http://www.crusadebleedingscore.org http://www.ahjonline.com/article/S0002-8703(08)00384-0/abstract 8-4-2015 Eduard van den Berg, cardio.nl 31 8-4-2015 Eduard van den Berg, cardio.nl 32 8-4-2015 Eduard van den Berg, cardio.nl 33 8-4-2015 Eduard van den Berg, cardio.nl 34 8-4-2015 Eduard van den Berg, cardio.nl 35 8-4-2015 Eduard van den Berg, cardio.nl 36